DR. WOOSEUNG LEE M.D. NPI 1457500688

NPI Details

DR. Wooseung Lee, M.D. is an internal medicine in Chelmsford, MA with 40 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Wooseung Lee, M.D. NPI is 1457500688. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

228 BILLERICA RD
CHELMSFORD, MA
ZIP 01824-604
Phone: (978) 250-6100
Fax: (978) 250-6002

The NPI 1457500688 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood creatinine level (HCPCS:82565)
• Hemoglobin a1c level (HCPCS:83036)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Blood potassium level (HCPCS:84132)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood sodium level (HCPCS:84295)
• Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) (HCPCS:80051)
• Vitamin d-3 level (HCPCS:82306)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Iron level (HCPCS:83540)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood glucose (sugar) level (HCPCS:82947)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Phosphate level (HCPCS:84100)
• Automated urinalysis test (HCPCS:81003)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Calcium level, total (HCPCS:82310)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Uric acid level, blood (HCPCS:84550)
• Albumin (protein) level (HCPCS:82040)
• Liver function blood test panel (HCPCS:80076)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Ferritin (blood protein) level (HCPCS:82728)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)

The enumeration date for this NPI number is 9/11/2008 and was last updated on 2/18/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: